Assessing the role of primary healthy microglia and gap junction blocker in hindering Alzheimer's disease neuroinflammatory type: Early approaches for therapeutic intervention.

Front Neurosci · 2022 · PMC9871931 · PMID 36704003

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

highly significantp < 0.05actually significant

On the other hand, a very highly significant improvement was also observed in the PHM- and CBX-treated groups (week 3) with respect to the LPS-induced groups ( p < 0.05) ( Figure 9 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.